MIRA
INFORM REPORT
|
Report Date : |
16.05.2011 |
IDENTIFICATION DETAILS
|
Name : |
DONGHO PHARM.
CO., LTD. |
|
|
|
|
Registered Office : |
640-4, Irwon 1-dong, Gangnam-gu |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
27.01.2000 |
|
|
|
|
Com. Reg. No.: |
130-81-65074 |
|
|
|
|
Legal Form : |
Co., Ltd by shares |
|
|
|
|
Line of Business : |
Wholesale of Pharmaceuticals |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2010
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Basic
|
Company
Name |
DONGHO PHARM.
CO., LTD. (Korean Company
Name : “(주)동호팜”) |
|
Registered Address |
640-4, Irwon 1-dong, Gangnam-gu, |
|
Building |
Rm. 601, Dongho Bldg. |
|
Zip Code |
135-943 |
|
Tel |
+82-2-445-5151 |
|
Fax |
+82-2-445-6363 |
|
E-mail |
|
|
Trading Address |
Rm. 601, Dongho Bldg., 640-4, Irwon
1-dong, Gangnam-gu, |
|
Tel |
+82-2-445-5151 |
|
Fax |
+82-2-445-6363 |
|
Type |
Import |
|
Industry |
Wholesale of Pharmaceuticals |
|
Main Business |
Medicine, Food and Food Additives, Medical Devices, Cosmetics |
|
Established (mm/dd/yyyy) |
01/27/2000 |
The Subject Company
occupies the premises of registered HQ address by leasing base.
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Drugs and Pharmaceutical Products(51000000) |
|
Sell |
Cosmetics(53131619) |
CEO’s
|
Name |
Lim Dong-Ha |
|
Address |
Rm. G-5903, 467-29, Dogok-dong,
Gangnam-gu, |
|
Date of Birth |
11/11/1949 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital (KRW) |
50,000,000 |
||||||||||||||||||
|
Employees |
3 |
||||||||||||||||||
|
Formation |
Co., Ltd by shares |
||||||||||||||||||
|
Bank Details |
Kookmin Bank |
||||||||||||||||||
|
Corporate Registered No. |
121111-0072892 |
||||||||||||||||||
|
Business Registered No. |
130-81-65074 |
||||||||||||||||||
|
Permit & Licenses |
Int’l Trade No.: 545307 |
||||||||||||||||||
|
Shareholder Position |
|
||||||||||||||||||
|
Company History |
07/1990 Established as Sole Proprietorship
Type of Company 01/27/2000 Incorporated as Dongho Co., Ltd. 02/26/2007 Changed company name to the
present name 02/26/2007 Moved to the present HQ address
from Dongho Bldg., 2-2, Wonmi-dong, Wonmi-gu ,Bucheon-si, |
||||||||||||||||||
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Lim Dong-Ha |
Male |
Korean |
01/27/2000 |
|
Director |
Mr. |
Cho Han-Jin |
Male |
Korean |
01/27/2003 |
|
Director |
Mr. |
Choi Byung-Hoo |
Male |
Korean |
01/27/2003 |
|
Auditor |
M/S. |
Lee Jong-Hee |
Female |
Korean |
01/27/2003 |
Financials
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
2004 |
1,788.000,000 |
|
|
|
2003 |
1,917,000,000 |
|
|
The latest &
full financials are not available, and the Subject Company does not have any obligations
to release its financials to the public.
Financial Description
|
Authorized Capital(KRW) |
200,000,000 |
|
Paid-Up Capital(KRW) |
50,000,000 |
|
Total Issues Shares |
10,000 |
Products, Technologies, Services Description
|
Main Products & Services |
Medicine, Food and Food Additives, Medical Devices, Cosmetics |
Trade Partners & Competitors
|
Competitors |
BAEK JE PHARMACEUTICAL CO.,
LTD. 105, NAMGYO-DONG, MOKPO-SI, TEL:+82-61-244-5181 FAX:+82-61-244-5185 BOKSAN PHARM. CO., LTD. 825-13, BEOMIL 2-DONG, DONG-GU,
TEL:+82-51-667-1511 FAX:+82-51-645-2365 ORYOUNG INC. 1150-6, JAESONG 2-DONG,
HAEUNDAE-GU, TEL:+82-51-784-5500 FAX:+82-51-784-5356 |
News Clipping
---
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.68 |
|
|
1 |
Rs.73.04 |
|
Euro |
1 |
Rs.64.29 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.